MONBILAST

Description

MONBILAST is a next-generation nonsedating H1 antihistamine that combines Bilastine (20 mg) and Montelukast (10 mg) for effective control of allergic conditions such as rhinitis, urticaria, and mild asthma.

Composition:

• Bilastine (20 mg) – A second-generation H1-antihistamine with superior efficacy and better tolerability than Desloratadine or Cetirizine.

• Montelukast (10 mg) – A leukotriene receptor antagonist that reduces inflammation, bronchoconstriction, and mucus production.

Uses:

• Seasonal/Perennial Allergic Rhinitis

• Chronic Urticaria (hives)

• Mild to Moderate Asthma

• Relief from nasal congestion, sneezing, watery eyes, and wheezing

Combination Advantage:

• Superior to monotherapy

• Sustained and longer duration of action

• Faster onset of symptom relief

• Additive therapeutic effect for better overall symptom control

Dosage & Administration:

• 1 tablet daily

• To be taken 1 hour before food or 2 hours after food for optimal absorption

Side Effects:

• Headache, abdominal discomfort

• Sleep disturbances (rare)

• Drowsiness (very rare with Bilastine)

• Hypersensitivity (rare)

Precautions:

• Not recommended for children under 12 without medical advice

• Use with caution in patients with severe liver dysfunction

• Should not be combined with alcohol or other CNS depressants

• Avoid in pregnancy or lactation unless clearly needed